Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
71,366,920
-
Total 13F shares
-
34,463,769
-
Share change
-
+2,216,208
-
Total reported value
-
$1,541,455,693
-
Price per share
-
$44.68
-
Number of holders
-
111
-
Value change
-
+$108,870,130
-
Number of buys
-
68
-
Number of sells
-
32
Institutional Holders of C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC) as of Q3 2021
As of 30 Sep 2021 C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC) had 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,463,769 shares of stock of the company.
Largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., RTW INVESTMENTS, LP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, STATE STREET CORP, Bain Capital Life Sciences Investors, LLC, ArrowMark Colorado Holdings LLC, RA CAPITAL MANAGEMENT, L.P., and WASATCH ADVISORS INC.
This table shows 111 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.